Literature DB >> 36214835

Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Kevin Ferrao1, Najma Ali1, Kosha J Mehta2.   

Abstract

Alcohol-associated liver disease (ALD) is one of the most common chronic liver diseases. Its pathological spectrum includes the overlapping stages of hepatic steatosis/steatohepatitis that can progress to liver fibrosis and cirrhosis; both are risk factors for hepatocellular carcinoma. Moreover, ALD diagnosis and management pose several challenges. The early pathological stages are reversible by alcohol abstinence, but these early stages are often asymptomatic, and currently, there is no specific laboratory biomarker or diagnostic test that can confirm ALD etiology. Alcohol consumers frequently show dysregulation of iron and iron-related proteins. Examination of iron-related parameters in this group may aid in early disease diagnosis and better prognosis and management. For this, a coherent overview of the status of iron and iron-related proteins in alcohol consumers is essential. Therefore, here, we collated and reviewed the alcohol-induced alterations in iron and iron-related proteins. Reported observations include unaltered, increased, or decreased levels of hemoglobin and serum iron, increments in intestinal iron absorption (facilitated via upregulations of duodenal divalent metal transporter-1 and ferroportin), serum ferritin and carbohydrate-deficient transferrin, decrements in serum hepcidin, decreased or unaltered levels of transferrin, increased or unaltered levels of transferrin saturation, and unaltered levels of soluble transferrin receptor. Laboratory values of iron and iron-related proteins in alcohol consumers are provided for reference. The causes and mechanisms underlying these alcohol-induced alterations in iron parameters and anemia in ALD are explained. Notably, alcohol consumption by hemochromatosis (iron overload) patients worsens disease severity due to the synergistic effects of excess iron and alcohol.
© 2022. The Author(s).

Entities:  

Keywords:  ALD; Alcohol; Alcohol-associated liver disease; Carbohydrate-deficient transferrin; Ferritin; Hemoglobin; Hepcidin; Iron; Transferrin; Transferrin receptor-1

Year:  2022        PMID: 36214835     DOI: 10.1007/s00109-022-02254-8

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  71 in total

1.  Iron Enhances Hepatic Fibrogenesis and Activates Transforming Growth Factor-β Signaling in Murine Hepatic Stellate Cells.

Authors:  Kosha J Mehta; Jason D Coombes; Marco Briones-Orta; Paul P Manka; Roger Williams; Vinood B Patel; Wing-Kin Syn
Journal:  Am J Med Sci       Date:  2017-08-23       Impact factor: 2.378

Review 2.  Regulation of the Iron Homeostatic Hormone Hepcidin.

Authors:  Veena Sangkhae; Elizabeta Nemeth
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701

Review 3.  Role of iron and iron-related proteins in mesenchymal stem cells: Cellular and clinical aspects.

Authors:  Kosha J Mehta
Journal:  J Cell Physiol       Date:  2021-04-05       Impact factor: 6.384

4.  Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.

Authors:  David W Crabb; Gene Y Im; Gyongyi Szabo; Jessica L Mellinger; Michael R Lucey
Journal:  Hepatology       Date:  2020-01       Impact factor: 17.425

Review 5.  Is the iron regulatory hormone hepcidin a risk factor for alcoholic liver disease?

Authors:  Duygu Dee Harrison-Findik
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

6.  The effect of alcohol consumption on the prevalence of iron overload, iron deficiency, and iron deficiency anemia.

Authors:  George N Ioannou; Jason A Dominitz; Noel S Weiss; Patrick J Heagerty; Kris V Kowdley
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

Review 7.  Diagnosis of alcoholic liver disease.

Authors:  Cara Torruellas; Samuel W French; Valentina Medici
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 8.  Iron and liver fibrosis: Mechanistic and clinical aspects.

Authors:  Kosha J Mehta; Sebastien Je Farnaud; Paul A Sharp
Journal:  World J Gastroenterol       Date:  2019-02-07       Impact factor: 5.742

Review 9.  Iron at the Interface of Hepatocellular Carcinoma.

Authors:  Rossana Paganoni; André Lechel; Maja Vujic Spasic
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

Review 10.  Betaine in ameliorating alcohol-induced hepatic steatosis.

Authors:  Aisha Rehman; Kosha J Mehta
Journal:  Eur J Nutr       Date:  2021-11-24       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.